

The Synovasure Alpha Defensin Lateral Flow Test is a standalone, rapid device for detecting alpha defensin in synovial fluid. The test received FDA authorization in 2019 as a CLIA moderately complex test.
Results in 10 minutes following performance of test.
Demonstrates a high sensitivity (94.3%) and specificity (94.5%). In addition, results proven in clinical studies to be unaffected by:
Only needs 15 microliters of synovial fluid to perform test.
No statistically significant difference in performance of Synovasure Alpha Defensin Lateral Flow Test and Synovasure Alpha Defensin ELISA laboratory test.
Infection Diagnostics
Revision Knee
Revision Hip
Periprosthetic Joint Infection (PJI) is one of the most common complications following total joint arthroplasty.2 The Synovasure Alpha Defensin Lateral Flow Test offers a rapid and accurate positive/negative result (10 minutes) to aid in the diagnosis of PJI.